Item 8.01 Other Events

On September 26, 2022, DURECT Corporation issued a press release announcing that POSIMIR® (bupivacaine solution) is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits




    99.1   Press Release of DURECT Corporation dated September 26, 20  22
    104  Cover Page Interactive Data File (embedded within the Inline XBRL
         document)











                                       3

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses